NK
Nasiya Kalappurakal Aliyar
About Nasiya Kalappurakal Aliyar
Data last updated:
Nasiya Kalappurakal Aliyar is a Director at Zygene Biotechnologies Private Limited (since 2019). The company operates in Life Sciences. Zygene Biotechnologies Private Limited reported revenue of ₹7.3 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zygene Biotechnologies Private Limited U85100KL2019PTC058542 | Director | 24 Jun 2019 | 2019 | ₹7.3 Lakh (FY 2024) | Active |
Board colleagues of Nasiya Kalappurakal Aliyar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rishad Sayedmuhammed Kalappurakkal | 07920393 | Zygene Biotechnologies Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nasiya Kalappurakal Aliyar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nasiya Kalappurakal Aliyar
Nasiya Kalappurakal Aliyar currently holds 1 directorship: Zygene Biotechnologies Private Limited (Director, since 24 Jun 2019, revenue ₹7.3 Lakh (FY 2024)).
Nasiya Kalappurakal Aliyar was first appointed on 24 Jun 2019 as Director at Zygene Biotechnologies Private Limited.
The current boards of Nasiya Kalappurakal Aliyar's companies include Rishad Sayedmuhammed Kalappurakkal (Zygene Biotechnologies Private Limited).